CSIMarket
 


Sight Sciences Inc   (SGHT)
Other Ticker:  
 
 

SGHT's Revenue Growth by Quarter and Year

Sight Sciences Inc 's Revenue results by quarter and year




SGHT Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 20.54 -25.64 0.00
III Quarter September 19.33 18.68 13.10 0.00
II Quarter June 23.09 17.23 12.54 0.00
I Quarter March 18.82 14.88 0.00 0.00
FY   61.24 71.33 0.00 0.00



SGHT Revenue third quarter 2023 Y/Y Growth Comment
Sight Sciences Inc reported Revenue growth of 3.49% year on year in the third quarter 2023, to $ 19.33 millions, this is lower than Sight Sciences Inc 's recent average Revenue improvement of 28.81%.

Looking into third quarter 2023 results within Medical Equipment & Supplies industry 116 other companies have achieved higher Revenue growth. While Sight Sciences Inc ' s Revenue increase of 3.49% ranks overall at the positon no. 1821 in the third quarter 2023.




SGHT Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September 3.49 % 42.6 % - -
II Quarter June 34.01 % 37.4 % - -
I Quarter March 26.48 % - - -
FY   - - - -

Financial Statements
Sight Sciences Inc 's third quarter 2023 Revenue $ 19.33 millions SGHT's Income Statement
Sight Sciences Inc 's third quarter 2022 Revenue $ 18.68 millions Quarterly SGHT's Income Statement
New: More SGHT's historic Revenue Growth >>


SGHT Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - 9.96 % - -
III Quarter September -16.28 % 8.42 % 4.47 % -
II Quarter June 22.69 % 15.79 % - -
I Quarter March -8.37 % - - -
FY (Year on Year)   - - - -




Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #117
Healthcare Sector #363
Overall #1821

Revenue Y/Y Growth Statistics
High Average Low
42.56 % 28.81 % 3.51 %
(Sep 30 2022)   (Sep 30 2023)
Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #117
Healthcare Sector #363
Overall #1821
Revenue Y/Y Growth Statistics
High Average Low
42.56 % 28.81 % 3.51 %
(Sep 30 2022)   (Sep 30 2023)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Sight Sciences Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
22.66 % 5.24 % -16.28 %
(Jun 30 2023)  


SGHT's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2023 Sight Sciences Inc reported fall in Revenue from the second quarter by -16.28% to $ 19.33 millions, from $ 23.09 millions achived in the previous reporting period.

Those periodic factors have not rescue the III. Quarter for the Sight Sciences Inc , Luisa Ferreira, Healthcare sector veteran from London pointed out, she mentioned some skepticism towards Sight Sciences Inc 's direction and mentioned that average sequential Revenue growth is at 5.24% for the Medical Equipment & Supplies's company.

Within Medical Equipment & Supplies industry 149 other companies have achieved higher Revenue quarter on quarter growth. While Sight Sciences Inc 's Revenue growth quarter on quarter, overall rank is 3229.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #150
Healthcare Sector #501
Overall #3229
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #150
Healthcare Sector #501
Overall #3229
Revenue Q/Q Growth Statistics
High Average Low
22.66 % 5.24 % -16.28 %
(Jun 30 2023)  


SGHT's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2023 Sight Sciences Inc realized fall in Revenue from the previous quarter by -16.28% to $ 19.33 millions, from $ 23.09 millions released in the previous reporting period.

Those cyclical circumstance have not salvage the III. Quarter for the Sight Sciences Inc , Luisa Ferreira, Healthcare sector veteran from London said, she voiced little caution conserning Sight Sciences Inc 's outlook.

Within Medical Equipment & Supplies industry 149 other companies have achieved higher Revenue quarter on quarter growth. While Sight Sciences Inc 's Revenue growth quarter on quarter, overall rank is 3229.


Sight Sciences Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Revenue 12 Months Ending $ 81.79 $ 81.14 $ 75.27 $ 71.33 $ 25.15
Y / Y Revenue Growth (TTM) 225.2 % 314.48 % 405.84 % - -
Year on Year Revenue Growth Overall Ranking # 54 # 18 # 80 # 0 # 0
Seqeuential Revenue Change (TTM) 0.81 % 7.79 % 5.53 % 183.61 % 28.49 %
Seq. Revenue Growth (TTM) Overall Ranking # 620 # 338 # 659 # 471 # 574




Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2023 period, Sight Sciences Inc 's cumulative twelve months Revenue were $ 82 millions, company would post below average annual Revenue growth of 28.49% year on year, if the fiscal year would end at Sep 30 2023.
A slow-down in the Sight Sciences Inc 's Revenue growth from the 23.09% growth in Jun 30 2023.

Within the Healthcare sector 22 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 18 to 54.

Revenue TTM Q/Q Growth Statistics
High Average Low
405.84 %
315.17 %
225.2 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 40
Healthcare Sector # 23
Overall # 54

Revenue TTM Y/Y Growth Statistics
High Average Low
405.84 %
315.17 %
225.2 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 40
Sector # 168
S&P 500 # 620
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2023 period, Sight Sciences Inc 's cumulative twelve months Revenue were $ 82 millions, company would post below average annual Revenue growth of 225.2% year on year, if the fiscal year would end at Sep 30 2023.
A slow-down in the Sight Sciences Inc 's Revenue growth from the 23.09% growth in Jun 30 2023.

Within the Healthcare sector 22 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 18 to 54.

Revenue TTM Q/Q Growth Statistics
High Average Low
405.84 %
315.17 %
225.2 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 40
Healthcare Sector # 23
Overall # 54

Revenue TTM Y/Y Growth Statistics
High Average Low
405.84 %
315.17 %
225.2 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 40
Sector # 168
S&P 500 # 620




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
SGHT's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for SGHT's Competitors
Revenue Growth for Sight Sciences Inc 's Suppliers
Revenue Growth for SGHT's Customers

You may also want to know
SGHT's Annual Growth Rates SGHT's Profitability Ratios SGHT's Asset Turnover Ratio SGHT's Dividend Growth
SGHT's Roe SGHT's Valuation Ratios SGHT's Financial Strength Ratios SGHT's Dividend Payout Ratio
SGHT's Roa SGHT's Inventory Turnover Ratio SGHT's Growth Rates SGHT's Dividend Comparisons



Companies with similar Revenue fall for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2023
Meiragtx Holdings Plc5.96%$ 5.959 millions
Davita Inc 5.85%$ 5.855 millions
Sotera Health Company5.74%$ 5.742 millions
American Shared Hospital Services5.68%$ 5.675 millions
Staar Surgical Company5.60%$ 5.605 millions
Tenet Healthcare Corp5.52%$ 5.520 millions
Nature s Sunshine Products inc 5.48%$ 5.485 millions
Inspiremd Inc 5.27%$ 5.271 millions
Amarin Corp Plcuk5.09%$ 5.086 millions
Seer Inc 5.08%$ 5.082 millions
Luna Innovations Inc5.06%$ 5.063 millions
Zimmer Biomet Holdings Inc 5.02%$ 5.019 millions
Iqvia Holdings Inc 4.88%$ 4.885 millions
Ironwood Pharmaceuticals inc 4.70%$ 4.696 millions
Aclarion Inc 4.63%$ 4.626 millions
Aridis Pharmaceuticals Inc 4.51%$ 4.511 millions
Avalon Globocare Corp 4.38%$ 4.379 millions
Assertio Holdings inc 4.14%$ 4.136 millions
Integrated Biopharma Inc4.11%$ 4.105 millions
Innoviva Inc 3.93%$ 3.928 millions
Ufp Technologies Inc 3.90%$ 3.898 millions
Elanco Animal Health Inc3.89%$ 3.891 millions
Charles River Laboratories International inc 3.79%$ 3.788 millions
Amgen Inc 3.77%$ 3.773 millions
Owens and Minor inc 3.77%$ 3.768 millions
Sight Sciences Inc 3.51%$ 3.507 millions
Pediatrix Medical Group Inc 3.41%$ 3.408 millions
Halozyme Therapeutics Inc 3.38%$ 3.377 millions
Jazz Pharmaceuticals Plc3.35%$ 3.347 millions
Henry Schein Inc 3.10%$ 3.097 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com